Tag: Herceptin

Herceptin (trastuzumab): A monoclonal antibody used to treat HER2 overexpressing (HER2+) breast cancer. Herceptin works by binding to the HER2 receptor, thereby reducing the effects of overexpression of HER2.

Articles

News

10/07/20
Differences in HER2 expression between tumors affects outcomes
05/01/16
Six-month delay in starting Herceptin linked to reduced survival
05/23/15
Sulforaphane inhibits HER2+ and triple negative breast cancer
07/22/12
Inflammation can contribute to resistance to Herceptin
05/13/12
A story of long-term stage IV HER2+ breast cancer survival
04/19/12
Green tea polyphenol EGCG slows development of tamoxifen resistance
12/13/11
Metformin improves survival of diabetic women with HER2+ BC
12/01/11
Herceptin + anthracycline chemo increases risk of cardiomyopathy

Studies